BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND DDX3X, DDX14, 1654, ENSG00000215301, DBX, DDX3, HLP2 AND Prognosis
10 results:

  • 1. Structural variants involving MLLT10 fusion are associated with adverse outcomes in pediatric acute myeloid leukemia.
    Abla O; Ries RE; Triche T; Gerbing RB; Hirsch B; Raimondi S; Cooper T; Farrar JE; Buteyn N; Harmon LM; Wen H; Deshpande AJ; Kolb EA; Gamis AS; Aplenc R; Alonzo T; Meshinchi S
    Blood Adv; 2024 Apr; 8(8):2005-2017. PubMed ID: 38306602
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Failure of tofacitinib to achieve an objective response in a
    Wong J; Wall M; Corboy GP; Taubenheim N; Gregory GP; Opat S; Shortt J
    Cold Spring Harb Mol Case Stud; 2020 Aug; 6(4):. PubMed ID: 32843425
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. CD56-positive diffuse large B-cell lymphoma/leukemia with
    Liu Y; Shen J; Awal Issah M; Liu T; Zhou H; Fu H
    J Int Med Res; 2020 May; 48(5):300060520918087. PubMed ID: 32363958
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Somatic mutations in
    Gao LM; Zhao S; Zhang WY; Wang M; Li HF; Lizaso A; Liu WP
    Cancer Biol Ther; 2019; 20(10):1319-1327. PubMed ID: 31311407
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Unmanipulated haploidentical versus HLA-matched sibling allogeneic hematopoietic stem cell transplantation in relapsed/refractory acute myeloid leukemia: a retrospective study on behalf of the ALWP of the EBMT.
    Battipaglia G; Boumendil A; Labopin M; Ciceri F; Tischer J; Stelljes M; Ehninger G; Beelen D; Finke J; Van Lint MT; Eder M; Afanasyev B; Fanin R; Mohty M; Ruggeri A; Nagler A
    Bone Marrow Transplant; 2019 Sep; 54(9):1499-1510. PubMed ID: 30718798
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target.
    Dufva O; Kankainen M; Kelkka T; Sekiguchi N; Awad SA; Eldfors S; Yadav B; Kuusanmäki H; Malani D; Andersson EI; Pietarinen P; Saikko L; Kovanen PE; Ojala T; Lee DA; Loughran TP; Nakazawa H; Suzumiya J; Suzuki R; Ko YH; Kim WS; Chuang SS; Aittokallio T; Chan WC; Ohshima K; Ishida F; Mustjoki S
    Nat Commun; 2018 Apr; 9(1):1567. PubMed ID: 29674644
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Clinical implications of cancer gene mutations in patients with chronic lymphocytic leukemia treated with lenalidomide.
    Takahashi K; Hu B; Wang F; Yan Y; Kim E; Vitale C; Patel KP; Strati P; Gumbs C; Little L; Tippen S; Song X; Zhang J; Jain N; Thompson P; Garcia-Manero G; Kantarjian H; Estrov Z; Do KA; Keating M; Burger JA; Wierda WG; Futreal PA; Ferrajoli A
    Blood; 2018 Apr; 131(16):1820-1832. PubMed ID: 29358183
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Genomic Profile of Chronic Lymphocytic leukemia in Korea Identified by Targeted Sequencing.
    Kim JA; Hwang B; Park SN; Huh S; Im K; Choi S; Chung HY; Huh J; Seo EJ; Lee JH; Bang D; Lee DS
    PLoS One; 2016; 11(12):e0167641. PubMed ID: 27959900
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Comprehensive Analysis of Disease-Related Genes in Chronic Lymphocytic leukemia by Multiplex PCR-Based Next Generation Sequencing.
    Vollbrecht C; Mairinger FD; Koitzsch U; Peifer M; Koenig K; Heukamp LC; Crispatzu G; Wilden L; Kreuzer KA; Hallek M; Odenthal M; Herling CD; Buettner R
    PLoS One; 2015; 10(6):e0129544. PubMed ID: 26053404
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. SF3B1 and other novel cancer genes in chronic lymphocytic leukemia.
    Wang L; Lawrence MS; Wan Y; Stojanov P; Sougnez C; Stevenson K; Werner L; Sivachenko A; DeLuca DS; Zhang L; Zhang W; Vartanov AR; Fernandes SM; Goldstein NR; Folco EG; Cibulskis K; Tesar B; Sievers QL; Shefler E; Gabriel S; Hacohen N; Reed R; Meyerson M; Golub TR; Lander ES; Neuberg D; Brown JR; Getz G; Wu CJ
    N Engl J Med; 2011 Dec; 365(26):2497-506. PubMed ID: 22150006
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.